aluates Reports

$ 0.0

Automative

Global Adjuvanted Influenza Vaccine Market Research Report 2024

Published Date: August 2024

Report Code: QYRE-Auto-2T15772

Global Adjuvanted Influenza Vaccine Market Research Report 2023

BUY CHAPTERS

Global Adjuvanted Influenza Vaccine Market Research Report 2024

Code: QYRE-Auto-2T15772

Report

August 2024

Pages:75

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

CSL Limited

Adjuvanted Influenza Vaccine Market Size

The global Adjuvanted Influenza Vaccine market was valued at US$ 952.3 million in 2023 and is anticipated to reach US$ 2176.1 million by 2030, witnessing a CAGR of 12.2% during the forecast period 2024-2030.

Adjuvanted Influenza Vaccine Market

An adjuvanted influenza vaccine is a type of influenza vaccine that has a substance called an "adjuvant" added during the vaccine preparation process. Adjuvant is a substance that can enhance the immune response. It can improve the response of the immune system to vaccine components (such as viral antigens) after vaccination, thereby increasing the effect of immune protection.

A significant driver in the Influenza Vaccine market is the growing awareness of the importance of vaccination in preventing seasonal and pandemic influenza outbreaks. As healthcare organizations and governments worldwide promote vaccination as a crucial public health measure, there is an increasing demand for influenza vaccines. Additionally, advances in vaccine research and development, including the production of more effective and broader-spectrum vaccines, are driving market growth. One of the key challenges in this market is the need for frequent vaccine updates to match evolving influenza strains. The virus undergoes genetic changes, requiring annual adjustments to vaccine formulations. This presents logistical challenges for manufacturers in terms of timely production and distribution. Vaccine hesitancy and misinformation also pose challenges by impacting vaccination rates and public perception. Lastly, ensuring equitable access to vaccines, especially in low-income and underserved populations, remains a persistent challenge in the fight against influenza.

This report aims to provide a comprehensive presentation of the global market for Adjuvanted Influenza Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Adjuvanted Influenza Vaccine.

Report Scope

The Adjuvanted Influenza Vaccine market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Adjuvanted Influenza Vaccine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Adjuvanted Influenza Vaccine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Adjuvanted Influenza Vaccine Market Report

Report Metric	Details
Report Name	Adjuvanted Influenza Vaccine Market
Accounted market size in 2023	US$ 952.3 million
Forecasted market size in 2030	US$ 2176.1 million
CAGR	12.2%
Base Year	2023
Forecasted years	2024 - 2030
Segment by Type	Vial Prefilled
Segment by Application	Public Sector Private Sector
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	CSL
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Adjuvanted Influenza Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Adjuvanted Influenza Vaccine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

FAQ for this report

How fast is Adjuvanted Influenza Vaccine Market growing?

Ans: The Adjuvanted Influenza Vaccine Market witnessing a CAGR of 12.2% during the forecast period 2024-2030.

What is the Adjuvanted Influenza Vaccine Market size in 2030?

Ans: The Adjuvanted Influenza Vaccine Market size in 2030 will be US$ 2176.1 million.

Who are the main players in the Adjuvanted Influenza Vaccine Market report?

Ans: The main players in the Adjuvanted Influenza Vaccine Market are CSL

What are the Application segmentation covered in the Adjuvanted Influenza Vaccine Market report?

Ans: The Applications covered in the Adjuvanted Influenza Vaccine Market report are Public Sector, Private Sector

What are the Type segmentation covered in the Adjuvanted Influenza Vaccine Market report?

Ans: The Types covered in the Adjuvanted Influenza Vaccine Market report are Vial, Prefilled

1 Adjuvanted Influenza Vaccine Market Overview

1.1 Product Overview and Scope of Adjuvanted Influenza Vaccine

1.2 Adjuvanted Influenza Vaccine Segment by Type

1.2.1 Global Adjuvanted Influenza Vaccine Market Value Comparison by Type (2024-2030)

1.2.2 Vial

1.2.3 Prefilled

1.3 Adjuvanted Influenza Vaccine Segment by Application

1.3.1 Global Adjuvanted Influenza Vaccine Market Value by Application: (2024-2030)

1.3.2 Public Sector

1.3.3 Private Sector

1.4 Global Adjuvanted Influenza Vaccine Market Size Estimates and Forecasts

1.4.1 Global Adjuvanted Influenza Vaccine Revenue 2019-2030

1.4.2 Global Adjuvanted Influenza Vaccine Sales 2019-2030

1.4.3 Global Adjuvanted Influenza Vaccine Market Average Price (2019-2030)

1.5 Assumptions and Limitations

2 Adjuvanted Influenza Vaccine Market Competition by Manufacturers

2.1 Global Adjuvanted Influenza Vaccine Sales Market Share by Manufacturers (2019-2024)

2.2 Global Adjuvanted Influenza Vaccine Revenue Market Share by Manufacturers (2019-2024)

2.3 Global Adjuvanted Influenza Vaccine Average Price by Manufacturers (2019-2024)

2.4 Global Adjuvanted Influenza Vaccine Industry Ranking 2022 VS 2023 VS 2024

2.5 Global Key Manufacturers of Adjuvanted Influenza Vaccine, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of Adjuvanted Influenza Vaccine, Product Type & Application

2.7 Adjuvanted Influenza Vaccine Market Competitive Situation and Trends

2.7.1 Adjuvanted Influenza Vaccine Market Concentration Rate

2.7.2 The Global Top 5 and Top 10 Largest Adjuvanted Influenza Vaccine Players Market Share by Revenue

2.7.3 Global Adjuvanted Influenza Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

2.8 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Adjuvanted Influenza Vaccine Retrospective Market Scenario by Region

3.1 Global Adjuvanted Influenza Vaccine Market Size by Region: 2019 Versus 2023 Versus 2030

3.2 Global Adjuvanted Influenza Vaccine Global Adjuvanted Influenza Vaccine Sales by Region: 2019-2030

3.2.1 Global Adjuvanted Influenza Vaccine Sales by Region: 2019-2024

3.2.2 Global Adjuvanted Influenza Vaccine Sales by Region: 2025-2030

3.3 Global Adjuvanted Influenza Vaccine Global Adjuvanted Influenza Vaccine Revenue by Region: 2019-2030

3.3.1 Global Adjuvanted Influenza Vaccine Revenue by Region: 2019-2024

3.3.2 Global Adjuvanted Influenza Vaccine Revenue by Region: 2025-2030

3.4 North America Adjuvanted Influenza Vaccine Market Facts & Figures by Country

3.4.1 North America Adjuvanted Influenza Vaccine Market Size by Country: 2019 VS 2023 VS 2030

3.4.2 North America Adjuvanted Influenza Vaccine Sales by Country (2019-2030)

3.4.3 North America Adjuvanted Influenza Vaccine Revenue by Country (2019-2030)

3.4.4 United States

3.4.5 Canada

3.5 Europe Adjuvanted Influenza Vaccine Market Facts & Figures by Country

3.5.1 Europe Adjuvanted Influenza Vaccine Market Size by Country: 2019 VS 2023 VS 2030

3.5.2 Europe Adjuvanted Influenza Vaccine Sales by Country (2019-2030)

3.5.3 Europe Adjuvanted Influenza Vaccine Revenue by Country (2019-2030)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Adjuvanted Influenza Vaccine Market Facts & Figures by Country

3.6.1 Asia Pacific Adjuvanted Influenza Vaccine Market Size by Country: 2019 VS 2023 VS 2030

3.6.2 Asia Pacific Adjuvanted Influenza Vaccine Sales by Country (2019-2030)

3.6.3 Asia Pacific Adjuvanted Influenza Vaccine Revenue by Country (2019-2030)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 China Taiwan

3.6.10 Southeast Asia

3.7 Latin America Adjuvanted Influenza Vaccine Market Facts & Figures by Country

3.7.1 Latin America Adjuvanted Influenza Vaccine Market Size by Country: 2019 VS 2023 VS 2030

3.7.2 Latin America Adjuvanted Influenza Vaccine Sales by Country (2019-2030)

3.7.3 Latin America Adjuvanted Influenza Vaccine Revenue by Country (2019-2030)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.7.7 Colombia

3.8 Middle East and Africa Adjuvanted Influenza Vaccine Market Facts & Figures by Country

3.8.1 Middle East and Africa Adjuvanted Influenza Vaccine Market Size by Country: 2019 VS 2023 VS 2030

3.8.2 Middle East and Africa Adjuvanted Influenza Vaccine Sales by Country (2019-2030)

3.8.3 Middle East and Africa Adjuvanted Influenza Vaccine Revenue by Country (2019-2030)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 UAE

4 Segment by Type

4.1 Global Adjuvanted Influenza Vaccine Sales by Type (2019-2030)

4.1.1 Global Adjuvanted Influenza Vaccine Sales by Type (2019-2024)

4.1.2 Global Adjuvanted Influenza Vaccine Sales by Type (2025-2030)

4.1.3 Global Adjuvanted Influenza Vaccine Sales Market Share by Type (2019-2030)

4.2 Global Adjuvanted Influenza Vaccine Revenue by Type (2019-2030)

4.2.1 Global Adjuvanted Influenza Vaccine Revenue by Type (2019-2024)

4.2.2 Global Adjuvanted Influenza Vaccine Revenue by Type (2025-2030)

4.2.3 Global Adjuvanted Influenza Vaccine Revenue Market Share by Type (2019-2030)

4.3 Global Adjuvanted Influenza Vaccine Price by Type (2019-2030)

5 Segment by Application

5.1 Global Adjuvanted Influenza Vaccine Sales by Application (2019-2030)

5.1.1 Global Adjuvanted Influenza Vaccine Sales by Application (2019-2024)

5.1.2 Global Adjuvanted Influenza Vaccine Sales by Application (2025-2030)

5.1.3 Global Adjuvanted Influenza Vaccine Sales Market Share by Application (2019-2030)

5.2 Global Adjuvanted Influenza Vaccine Revenue by Application (2019-2030)

5.2.1 Global Adjuvanted Influenza Vaccine Revenue by Application (2019-2024)

5.2.2 Global Adjuvanted Influenza Vaccine Revenue by Application (2025-2030)

5.2.3 Global Adjuvanted Influenza Vaccine Revenue Market Share by Application (2019-2030)

5.3 Global Adjuvanted Influenza Vaccine Price by Application (2019-2030)

6 Key Companies Profiled

6.1 CSL

6.1.1 CSL Corporation Information

6.1.2 CSL Description and Business Overview

6.1.3 CSL Adjuvanted Influenza Vaccine Sales, Revenue and Gross Margin (2019-2024)

6.1.4 CSL Adjuvanted Influenza Vaccine Product Portfolio

6.1.5 CSL Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 Adjuvanted Influenza Vaccine Industry Chain Analysis

7.2 Adjuvanted Influenza Vaccine Key Raw Materials

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Adjuvanted Influenza Vaccine Production Mode & Process

7.4 Adjuvanted Influenza Vaccine Sales and Marketing

7.4.1 Adjuvanted Influenza Vaccine Sales Channels

7.4.2 Adjuvanted Influenza Vaccine Distributors

7.5 Adjuvanted Influenza Vaccine Customers

8 Adjuvanted Influenza Vaccine Market Dynamics

8.1 Adjuvanted Influenza Vaccine Industry Trends

8.2 Adjuvanted Influenza Vaccine Market Drivers

8.3 Adjuvanted Influenza Vaccine Market Challenges

8.4 Adjuvanted Influenza Vaccine Market Restraints

9 Research Finding and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

CSL Limited

List of Tables

Table 1. Global Adjuvanted Influenza Vaccine Market Value Comparison by Type (2024-2030) & (US$ Million)

Table 2. Global Adjuvanted Influenza Vaccine Market Value Comparison by Application (2024-2030) & (US$ Million)

Table 3. Global Adjuvanted Influenza Vaccine Market Competitive Situation by Manufacturers in 2023

Table 4. Global Adjuvanted Influenza Vaccine Sales (K Units) of Key Manufacturers (2019-2024)

Table 5. Global Adjuvanted Influenza Vaccine Sales Market Share by Manufacturers (2019-2024)

Table 6. Global Adjuvanted Influenza Vaccine Revenue (US$ Million) by Manufacturers (2019-2024)

Table 7. Global Adjuvanted Influenza Vaccine Revenue Share by Manufacturers (2019-2024)

Table 8. Global Market Adjuvanted Influenza Vaccine Average Price (US$/Unit) of Key Manufacturers (2019-2024)

Table 9. Global Key Players of Adjuvanted Influenza Vaccine, Industry Ranking, 2022 VS 2023 VS 2024

Table 10. Global Key Manufacturers of Adjuvanted Influenza Vaccine, Manufacturing Sites & Headquarters

Table 11. Global Key Manufacturers of Adjuvanted Influenza Vaccine, Product Type & Application

Table 12. Global Key Manufacturers of Adjuvanted Influenza Vaccine, Date of Enter into This Industry

Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Adjuvanted Influenza Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Adjuvanted Influenza Vaccine as of 2023)

Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 16. Global Adjuvanted Influenza Vaccine Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Table 17. Global Adjuvanted Influenza Vaccine Sales by Region (2019-2024) & (K Units)

Table 18. Global Adjuvanted Influenza Vaccine Sales Market Share by Region (2019-2024)

Table 19. Global Adjuvanted Influenza Vaccine Sales by Region (2025-2030) & (K Units)

Table 20. Global Adjuvanted Influenza Vaccine Sales Market Share by Region (2025-2030)

Table 21. Global Adjuvanted Influenza Vaccine Revenue by Region (2019-2024) & (US$ Million)

Table 22. Global Adjuvanted Influenza Vaccine Revenue Market Share by Region (2019-2024)

Table 23. Global Adjuvanted Influenza Vaccine Revenue by Region (2025-2030) & (US$ Million)

Table 24. Global Adjuvanted Influenza Vaccine Revenue Market Share by Region (2025-2030)

Table 25. North America Adjuvanted Influenza Vaccine Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 26. North America Adjuvanted Influenza Vaccine Sales by Country (2019-2024) & (K Units)

Table 27. North America Adjuvanted Influenza Vaccine Sales by Country (2025-2030) & (K Units)

Table 28. North America Adjuvanted Influenza Vaccine Revenue by Country (2019-2024) & (US$ Million)

Table 29. North America Adjuvanted Influenza Vaccine Revenue by Country (2025-2030) & (US$ Million)

Table 30. Europe Adjuvanted Influenza Vaccine Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 31. Europe Adjuvanted Influenza Vaccine Sales by Country (2019-2024) & (K Units)

Table 32. Europe Adjuvanted Influenza Vaccine Sales by Country (2025-2030) & (K Units)

Table 33. Europe Adjuvanted Influenza Vaccine Revenue by Country (2019-2024) & (US$ Million)

Table 34. Europe Adjuvanted Influenza Vaccine Revenue by Country (2025-2030) & (US$ Million)

Table 35. Asia Pacific Adjuvanted Influenza Vaccine Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 36. Asia Pacific Adjuvanted Influenza Vaccine Sales by Region (2019-2024) & (K Units)

Table 37. Asia Pacific Adjuvanted Influenza Vaccine Sales by Region (2025-2030) & (K Units)

Table 38. Asia Pacific Adjuvanted Influenza Vaccine Revenue by Region (2019-2024) & (US$ Million)

Table 39. Asia Pacific Adjuvanted Influenza Vaccine Revenue by Region (2025-2030) & (US$ Million)

Table 40. Latin America Adjuvanted Influenza Vaccine Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 41. Latin America Adjuvanted Influenza Vaccine Sales by Country (2019-2024) & (K Units)

Table 42. Latin America Adjuvanted Influenza Vaccine Sales by Country (2025-2030) & (K Units)

Table 43. Latin America Adjuvanted Influenza Vaccine Revenue by Country (2019-2024) & (US$ Million)

Table 44. Latin America Adjuvanted Influenza Vaccine Revenue by Country (2025-2030) & (US$ Million)

Table 45. Middle East & Africa Adjuvanted Influenza Vaccine Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 46. Middle East & Africa Adjuvanted Influenza Vaccine Sales by Country (2019-2024) & (K Units)

Table 47. Middle East & Africa Adjuvanted Influenza Vaccine Sales by Country (2025-2030) & (K Units)

Table 48. Middle East & Africa Adjuvanted Influenza Vaccine Revenue by Country (2019-2024) & (US$ Million)

Table 49. Middle East & Africa Adjuvanted Influenza Vaccine Revenue by Country (2025-2030) & (US$ Million)

Table 50. Global Adjuvanted Influenza Vaccine Sales (K Units) by Type (2019-2024)

Table 51. Global Adjuvanted Influenza Vaccine Sales (K Units) by Type (2025-2030)

Table 52. Global Adjuvanted Influenza Vaccine Sales Market Share by Type (2019-2024)

Table 53. Global Adjuvanted Influenza Vaccine Sales Market Share by Type (2025-2030)

Table 54. Global Adjuvanted Influenza Vaccine Revenue (US$ Million) by Type (2019-2024)

Table 55. Global Adjuvanted Influenza Vaccine Revenue (US$ Million) by Type (2025-2030)

Table 56. Global Adjuvanted Influenza Vaccine Revenue Market Share by Type (2019-2024)

Table 57. Global Adjuvanted Influenza Vaccine Revenue Market Share by Type (2025-2030)

Table 58. Global Adjuvanted Influenza Vaccine Price (US$/Unit) by Type (2019-2024)

Table 59. Global Adjuvanted Influenza Vaccine Price (US$/Unit) by Type (2025-2030)

Table 60. Global Adjuvanted Influenza Vaccine Sales (K Units) by Application (2019-2024)

Table 61. Global Adjuvanted Influenza Vaccine Sales (K Units) by Application (2025-2030)

Table 62. Global Adjuvanted Influenza Vaccine Sales Market Share by Application (2019-2024)

Table 63. Global Adjuvanted Influenza Vaccine Sales Market Share by Application (2025-2030)

Table 64. Global Adjuvanted Influenza Vaccine Revenue (US$ Million) by Application (2019-2024)

Table 65. Global Adjuvanted Influenza Vaccine Revenue (US$ Million) by Application (2025-2030)

Table 66. Global Adjuvanted Influenza Vaccine Revenue Market Share by Application (2019-2024)

Table 67. Global Adjuvanted Influenza Vaccine Revenue Market Share by Application (2025-2030)

Table 68. Global Adjuvanted Influenza Vaccine Price (US$/Unit) by Application (2019-2024)

Table 69. Global Adjuvanted Influenza Vaccine Price (US$/Unit) by Application (2025-2030)

Table 70. CSL Corporation Information

Table 71. CSL Description and Business Overview

Table 72. CSL Adjuvanted Influenza Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 73. CSL Adjuvanted Influenza Vaccine Product

Table 74. CSL Recent Developments/Updates

Table 75. Key Raw Materials Lists

Table 76. Raw Materials Key Suppliers Lists

Table 77. Adjuvanted Influenza Vaccine Distributors List

Table 78. Adjuvanted Influenza Vaccine Customers List

Table 79. Adjuvanted Influenza Vaccine Market Trends

Table 80. Adjuvanted Influenza Vaccine Market Drivers

Table 81. Adjuvanted Influenza Vaccine Market Challenges

Table 82. Adjuvanted Influenza Vaccine Market Restraints

Table 83. Research Programs/Design for This Report

Table 84. Key Data Information from Secondary Sources

Table 85. Key Data Information from Primary Sources

List of Figures

Figure 1. Product Picture of Adjuvanted Influenza Vaccine

Figure 2. Global Adjuvanted Influenza Vaccine Market Value Comparison by Type (2024-2030) & (US$ Million)

Figure 3. Global Adjuvanted Influenza Vaccine Market Share by Type in 2023 & 2030

Figure 4. Vial Product Picture

Figure 5. Prefilled Product Picture

Figure 6. Global Adjuvanted Influenza Vaccine Market Value Comparison by Application (2024-2030) & (US$ Million)

Figure 7. Global Adjuvanted Influenza Vaccine Market Share by Application in 2023 & 2030

Figure 8. Public Sector

Figure 9. Private Sector

Figure 10. Global Adjuvanted Influenza Vaccine Revenue, (US$ Million), 2019 VS 2023 VS 2030

Figure 11. Global Adjuvanted Influenza Vaccine Market Size (2019-2030) & (US$ Million)

Figure 12. Global Adjuvanted Influenza Vaccine Sales (2019-2030) & (K Units)

Figure 13. Global Adjuvanted Influenza Vaccine Average Price (US$/Unit) & (2019-2030)

Figure 14. Adjuvanted Influenza Vaccine Report Years Considered

Figure 15. Adjuvanted Influenza Vaccine Sales Share by Manufacturers in 2023

Figure 16. Global Adjuvanted Influenza Vaccine Revenue Share by Manufacturers in 2023

Figure 17. The Global 5 and 10 Largest Adjuvanted Influenza Vaccine Players: Market Share by Revenue in 2023

Figure 18. Adjuvanted Influenza Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023

Figure 19. Global Adjuvanted Influenza Vaccine Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Figure 20. North America Adjuvanted Influenza Vaccine Sales Market Share by Country (2019-2030)

Figure 21. North America Adjuvanted Influenza Vaccine Revenue Market Share by Country (2019-2030)

Figure 22. United States Adjuvanted Influenza Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 23. Canada Adjuvanted Influenza Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 24. Europe Adjuvanted Influenza Vaccine Sales Market Share by Country (2019-2030)

Figure 25. Europe Adjuvanted Influenza Vaccine Revenue Market Share by Country (2019-2030)

Figure 26. Germany Adjuvanted Influenza Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 27. France Adjuvanted Influenza Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 28. U.K. Adjuvanted Influenza Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 29. Italy Adjuvanted Influenza Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 30. Russia Adjuvanted Influenza Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 31. Asia Pacific Adjuvanted Influenza Vaccine Sales Market Share by Region (2019-2030)

Figure 32. Asia Pacific Adjuvanted Influenza Vaccine Revenue Market Share by Region (2019-2030)

Figure 33. China Adjuvanted Influenza Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 34. Japan Adjuvanted Influenza Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 35. South Korea Adjuvanted Influenza Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 36. India Adjuvanted Influenza Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 37. Australia Adjuvanted Influenza Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 38. China Taiwan Adjuvanted Influenza Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 39. Southeast Asia Adjuvanted Influenza Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 40. Latin America Adjuvanted Influenza Vaccine Sales Market Share by Country (2019-2030)

Figure 41. Latin America Adjuvanted Influenza Vaccine Revenue Market Share by Country (2019-2030)

Figure 42. Mexico Adjuvanted Influenza Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 43. Brazil Adjuvanted Influenza Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 44. Argentina Adjuvanted Influenza Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 45. Colombia Adjuvanted Influenza Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 46. Middle East & Africa Adjuvanted Influenza Vaccine Sales Market Share by Country (2019-2030)

Figure 47. Middle East & Africa Adjuvanted Influenza Vaccine Revenue Market Share by Country (2019-2030)

Figure 48. Turkey Adjuvanted Influenza Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 49. Saudi Arabia Adjuvanted Influenza Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 50. UAE Adjuvanted Influenza Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 51. Global Sales Market Share of Adjuvanted Influenza Vaccine by Type (2019-2030)

Figure 52. Global Revenue Market Share of Adjuvanted Influenza Vaccine by Type (2019-2030)

Figure 53. Global Adjuvanted Influenza Vaccine Price (US$/Unit) by Type (2019-2030)

Figure 54. Global Sales Market Share of Adjuvanted Influenza Vaccine by Application (2019-2030)

Figure 55. Global Revenue Market Share of Adjuvanted Influenza Vaccine by Application (2019-2030)

Figure 56. Global Adjuvanted Influenza Vaccine Price (US$/Unit) by Application (2019-2030)

Figure 57. Adjuvanted Influenza Vaccine Value Chain

Figure 58. Adjuvanted Influenza Vaccine Production Process

Figure 59. Channels of Distribution (Direct Vs Distribution)

Figure 60. Distributors Profiles

Figure 61. Bottom-up and Top-down Approaches for This Report

Figure 62. Data Triangulation

Figure 63. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions